Contemporary Evidence-Based Diagnosis and Management of Severe Coronary Artery Calcification.


Journal

Heart, lung & circulation
ISSN: 1444-2892
Titre abrégé: Heart Lung Circ
Pays: Australia
ID NLM: 100963739

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 31 10 2021
revised: 17 01 2022
accepted: 22 01 2022
pubmed: 2 3 2022
medline: 24 5 2022
entrez: 1 3 2022
Statut: ppublish

Résumé

Percutaneous treatment of heavily calcified coronary lesions remains a challenge for interventional cardiologists with increased risk of incomplete lesion preparation, suboptimal stent deployment, procedural complications, and a higher rate of acute and late stent failure. Adequate lesion preparation through calcium modification is crucial in optimising procedural outcomes. Several calcium modification devices and techniques exist, with rotational atherectomy the predominant treatment for severely calcified lesions. Novel technologies such as intravascular lithotripsy are now available and show promise as a less technical and highly effective approach for calcium modification. Emerging evidence also emphasises the value of detailed characterisation of calcification severity and distribution especially with intracoronary imaging for appropriate device selection and individualised treatment strategy. This review aims to provide an overview of the non-invasive and invasive evaluation of coronary calcification, discuss calcium modification techniques and propose an algorithm for the management of calcified coronary lesions.

Identifiants

pubmed: 35227609
pii: S1443-9506(22)00039-7
doi: 10.1016/j.hlc.2022.01.011
pii:
doi:

Substances chimiques

Calcium SY7Q814VUP

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

766-778

Informations de copyright

Copyright © 2022 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). All rights reserved.

Auteurs

Ata Doost (A)

Fiona Stanley Hospital, Perth, WA, Australia; Harry Perkins Institute of Medical Research, University of Western Australia, Perth, WA, Australia; King's College Hospital, London, UK.

James Rankin (J)

Fiona Stanley Hospital, Perth, WA, Australia; Harry Perkins Institute of Medical Research, University of Western Australia, Perth, WA, Australia.

James Sapontis (J)

Monash Heart, Monash Medical Centre, Melbourne, Vic, Australia.

Brian Ko (B)

Monash Heart, Monash Medical Centre, Melbourne, Vic, Australia.

Sidney Lo (S)

Liverpool Hospital, Sydney, NSW, Australia.

Biyanka Jaltotage (B)

Fiona Stanley Hospital, Perth, WA, Australia; Harry Perkins Institute of Medical Research, University of Western Australia, Perth, WA, Australia.

Girish Dwivedi (G)

Fiona Stanley Hospital, Perth, WA, Australia; Harry Perkins Institute of Medical Research, University of Western Australia, Perth, WA, Australia.

David Wood (D)

Centre for Cardiovascular Innovation, St. Paul's Hospital, Vancouver, BC, Canada.

Jonathan Byrne (J)

King's College Hospital, London, UK.

Janarthanan Sathananthan (J)

Centre for Cardiovascular Innovation, St. Paul's Hospital, Vancouver, BC, Canada.

Abdul Rahman Ihdayhid (AR)

Fiona Stanley Hospital, Perth, WA, Australia; Harry Perkins Institute of Medical Research, University of Western Australia, Perth, WA, Australia. Electronic address: abdul.ihdayhid@perkins.org.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH